Cancer in adolescents and young adults in north Netherlands (1989-2003): Increased incidence, stable survival and high incidence of second primary tumours

Annals of Oncology

Volumn 20, Issue 2, 2009, Pages 365-373

  van Gaal, J C ^a,b   Bastiaannet, E ^a   Schaapveld, M ^a   Otter, R ^a   Kluin Nelemans, J C ^b   de Bont, E S J M ^b   van der Graaf, W T A ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adolescents; Cancer; Epidemiology; Second primary; Young adults

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOMA; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; GERM CELL TUMOR; GROUPS BY AGE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; NETHERLANDS; OSTEOSARCOMA; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; SECOND CANCER; SEX RATIO; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY;

ADOLESCENT; CHILD; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHY; HUMANS; INCIDENCE; MALE; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 60549113727     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn588     Document Type: Article

References (38)

1. Bleyer A, OLeary M, Barr R, Ries LAG (eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, MD: National Cancer Institute 2006. NIH Pub. No. 06-5767.
2. The data on incidence and survival of children and adolescents in Europe; the ACCIS project. International Agency for Research on Cancer. Lyon, France. 2008. http://www-dep.iarc.fr.
3. Gloecker Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2003; 8(6): 539-540.
4. Automated Childhood Cancer Information System (ACCIS) 2008. International Agency for the Research on Cancer, Lyon, France. 2008 http://www-dep.iarc.fr/accis.htm.
5. Reedijk AM, Janssen-Heijnen ML, Louwman MW et al. Increasing incidence and improved survival of cancer in children and young adults in Southern Netherlands, 1973-1999. Eur J Cancer 2005; 41: 760-769.
6. Steliarova-Foucher E, Kaatsch P, Lacour B et al. Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 1915-1951.
7. Bleyer WA. Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials. Med Pediatr Oncol 2002; 38: 1-10.
8. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007; 121: 2233-2240.
9. International Classification of Diseases for Oncology (ICD-O-3), 3rd edition. Vlaams Kankerregistratienetwerk. Brussels, Belgium. 2000.
10. Birch JM, Alston RD, Kelsey AM et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002; 87: 1267-1274.
11. van Leeuwen FE, Stiggelbout AM. van den Belt-Dusebout AW et al. Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 1993; 11: 415-424.
12. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695-706.
13. Choudhury JB. Non-parametric confidence interval estimation for competing risks analysis: Application to contraceptive data. Stat Med 2002; 21: 1129-1144.
14. Eden T. Keynote comment: Challenges of teenage and young-adult oncology. Lancet Oncol 2006; 7: 612-613.
15. Bleyer A. The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 2005; 35: 182-217.
16. Pollock BH. Where adolescents and young adults with cancer receive their care: Does it matter? J Clin Oncol 2007; 25: 4522-4523.
17. Kankerregistratie. Integraal Kanker Centrum. Utrecht, The Netherlands 2008. http://www.ikcnet.nl/page.php?id=41.
18. Birch JM, Alston RD, Quinn M, Kelsey AM. Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997. Eur J Cancer 2003; 39: 2622-2631.
19. Stiller CA, Desandes E, Danon SE et al. Cancer incidence and survival in European adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2006-2018.
20. Steliarova-Foucher E, Stiller CA, Pukkala E et al. Thyroid cancer incidence and survival among European children and adolescents (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2150-2169.
21. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: A review. J Urol 2003; 170: 5-11.
22. Clavel J, Steliarova-Foucher E, Berger C et al. Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project. Eur J Cancer 2006; 42: 2037-2049.
23. Bleyer WA, Tejeda H, Murphy SB et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 1997; 21: 366-373.
24. Howell DL, Ward KC, Austin HD et al. Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the state of Georgia. J Clin Oncol 2007; 25: 4610-4615.
25. Boissel N, Auclerc MF, Lheritier V et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774-780.
26. de Bont JM, van der Holt B, Dekker AW et al. Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols. Ned Tijdschr Geneeskd 2005; 149: 400-406.
27. de Bont JM, Holt B, Dekker AW et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004; 18: 2032-2035.
28. Albritton KH, Wiggins CH, Nelson HE, Weeks JC. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol 2007; 25: 4616-4621.
29. Dang-Tan T, Trottier H, Mery LS et al. Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008; 51(4): 468-474.
30. Bleyer A, Barr R, Hayes-Lattin B et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008; 8: 288-298.
31. Hudson MM, Jones D, Boyett J et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997; 15: 2205-2213.
32. Mertens AC, Yasui Y, Neglia JP et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
33. Skinner R, Wallace WH, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 2006; 7: 489-498.
34. Chaudru V, Chompret A, Bressac-de Paillerets B et al. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families. J Natl Cancer Inst 2004; 96: 785-795.
35. Hammal DM, Bell CL, Craft AW, Parker L. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer 2005; 45: 155-161.
36. Cardous-Ubbink MC, Heinen RC, Bakker PJ et al. Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 2007; 43: 351-362.
37. Robison LL, Green DM, Hudson M et al. Long-term outcomes of adult survivors of childhood cancer. Cancer 2005; 104(11 Suppl): 2557-2564.
38. MacArthur AC, Spinelli JJ, Rogers PC et al. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. Pediatr Blood Cancer 2007; 48: 453-459.